Barclays PLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	BUY	$1024.09 - $1201.76 $9.11 Million - $10.7 Million	8,900 New	8,900 $9.36 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $4.39 Million - $5.91 Million	-8,000 Reduced 53.33%	7,000 $4.14 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $5.85 Million - $7.18 Million	13,100 Added 689.47%	15,000 $7.1 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $12.5 Million - $15.1 Million	-22,900 Reduced 92.34%	1,900 $1.06 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $8.2 Million - $12.1 Million	-24,400 Reduced 49.59%	24,800 $12.1 Million
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $8.22 Million - $11.3 Million	-30,000 Reduced 37.88%	49,200 $18.5 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $1.34 Million - $1.56 Million	-4,900 Reduced 5.83%	79,200 $22 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $16.3 Million - $22.6 Million	54,500 Added 184.12%	84,100 $26.3 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $3.87 Million - $4.57 Million	-10,400 Reduced 26.0%	29,600 $12.2 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $3.06 Million - $3.67 Million	9,100 Added 29.45%	40,000 $14.9 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $12.1 Million - $14.1 Million	-34,600 Reduced 52.82%	30,900 $12.5 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $5.83 Million - $7.07 Million	20,500 Added 45.56%	65,500 $22.6 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $22.4 Million - $27.9 Million	-70,800 Reduced 61.14%	45,000 $15.5 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $14 Million - $18.4 Million	39,100 Added 50.98%	115,800 $43.5 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $33.1 Million - $38.7 Million	76,700	76,700 $34.3 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account